GIM
MLAB icon

Glenmede Investment Management’s Mesa Laboratories MLAB Stock Holding History

Glenmede Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$202K Sell
3,010
-139,498
-98% -$10M ﹤0.01% 1263
2025
Q2 		$13.4M Buy
+142,508
New +$15.6M 0.07% 276

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
SCM
Simcoe Capital Management New York $549M AUM 24.95% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

Glenmede Investment Management's MLAB Position: Q3 2025 in Review

Glenmede Investment Management reduced its Mesa Laboratories (MLAB) stake by 98% in Q3 2025, selling an estimated $10M and leaving 3,010 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

Glenmede Investment Management first reported a position in MLAB in Q2 2025 and has held it in 2 quarters since. The position peaked at $13.4M in Q2 2025. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

  • Glenmede Investment Management held 3,010 shares of Mesa Laboratories worth $202K as of Q3 2025.
  • Glenmede Investment Management sold 139,498 Mesa Laboratories shares in Q3 2025, an estimated $10M.
  • Mesa Laboratories made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1263 holding.
  • Glenmede Investment Management first reported a position in Mesa Laboratories in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Mesa Laboratories position peaked at $13.4M in Q2 2025.
  • 141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.